Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases
View All Articles in Issue
Page(s): 508-513
Download in electronic PDF format for $75
Abstract: As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 for their medication each year. This article discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.
Related Keywords:
Medicare Modernization Act of 2003, Medicare Part D, medication therapy management, chronic disease, barriers to implementation
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Nov/Dec 2008
Pg. 508-513
|
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008
Pg. 414-418
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Technology Spotlight: Barrier Isolators
Moussa Magdy, Rahe Hank, Lo Katharine
|
Jan/Feb 2003
Pg. 42-43
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
Home Infusion: Overcoming the Barriers to Entry
Franklin David M
|
Nov/Dec 2010
Pg. 450-455
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Karolchyk Scott
|
Nov/Dec 2001
Pg. 422-423
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1
Wagner James T
|
Mar/Apr 2006
Pg. 128-133
|
Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
|
May/Jun 2006
Pg. 208-211
|
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure
Park Young H, Pines E, Ofouku M, Cournoyer ME
|
Jul/Aug 2007
Pg. 338-346
|
Barrier Isolator/Glovebox Glove Dexterity Study
Park Young H, Pines E, Cournoyer M E
|
Nov/Dec 2010
Pg. 526-530
|
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Akers Michael J
|
Jul/Aug 2015
Pg. 315-320
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A, Cauffield Jacintha
|
May/Jun 2005
Pg. 201-205
|
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?
Rahe Hank
|
Jan/Feb 2005
Pg. 53-56
|
PostScription: Searching for Barrier Isolator Information?
Fink Carl, Newman John
|
Sep/Oct 2005
Pg. 407-408
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
| Return to Top |
